If women are screened for breast cancer every year, starting at the age of 40, their risk of mastectomy following breast cancer is considerably lower, researchers from The London Breast Institute, London, England, explained at the Annual Meeting of the Radiological Society of North America - RSNA 2010…
No Comments »
Filed under: Women's Health
WASHINGTON (MedPage Today) — An investigational diet drug combining naltrexone and bupropion (Contrave) comes with an increased risk of high blood pressure, and more studies on its safety may be needed, FDA staff reviewers said.
No Comments »
Filed under: General Health News
(MedPage Today) — Although France’s healthcare system is sometimes touted as a model the U.S. should look to, many French physicians think frequently about leaving medicine and more than 40% met criteria for burnout, a survey found.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The Obama administration issued new guidance Thursday for small businesses that want to take advantage of the new health insurance tax credit offered under the Affordable Care Act.
No Comments »
Filed under: General Health News
(MedPage Today) — GAITHERSBURG, Md. — An FDA advisory panel voted 5-0, with one abstention, that the benefits of Solesta, a bulking agent injected into the rectum to prevent fecal incontinence, outweigh its risks.
No Comments »
Filed under: General Health News
(MedPage Today) — With 2010 nearly over, the Department of Health and Human Services has updated its Healthy People program to reduce health risk factors and disparities, providing new topics and objectives for 2020.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — An FDA advisory panel decided that the benefits of the investigational cancer drug vandetanib (Zactima) appear to outweigh the drug’s considerable risks, but did not weigh in on whether it should be approved.
No Comments »
Filed under: General Health News
(MedPage Today) — A controversial article about problems with an implanted cardiac device — published by and then withdrawn from the journal Europace — has been resubmitted and is under review, according to the journal’s editor.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — An FDA advisory panel decided that the benefits of the investigational cancer drug vandetanib (Zactima) appear to outweigh the drug’s considerable risks, but did not weigh in on whether it should be approved.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — Johnson & Johnson-Merck Pharmaceuticals is recalling 12 Mylanta products and 12-oz AlternaGEL because the product label does not list the alcohol content of flavoring agents.
No Comments »
Filed under: Pharmacy News
